Founded in 2003 by Rebecka Belldegrun, M.D. and Arie Belldegrun, M.D., FACS, Bellco Capital is a direct investment firm that focuses on deploying capital in life science, real estate, consumer products, media, and other sectors.
The firm's founders have a background of biotechnology entrepreneurship, and created Breakthrough Properties to develop leading technologies. BellCo Capital is related to Breakthrough Properties as they look to develop and operate life science properties, and to support scientific innovations in biotechnologies, agriculture, and nutrition.
Dewpoint Therapeutics is a US-based drug manufacturing company.
Kronos Bio is a Cambridge, Massachusetts-based therapeutics company working on research and development of therapies that modulate historically recalcitrant cancer targets.